45 studies found for:    defend
Show Display Options
Rank Status Study
1 Completed Trial of Otelixizumab for Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-1
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: otelixizumab infusion plus physician determined standard of care;   Biological: placebo infusion plus physician determined standard of care
2 Completed Trial of Otelixizumab for Adolescents and Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-2
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: Otelixizumab;   Biological: Placebo
3 Not yet recruiting Comparison Between Desmopressin and Fesoterodine for Treatment of Night Time Voiding in Women Aged 65 and Older
Condition: Nocturia
Interventions: Drug: Desmopressin;   Drug: Fesoterodine
4 Completed Letrozole in the Treatment of Advanced or Recurrent Hormone Receptor Positive Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Drug: Letrozole
5 Recruiting Exercise and Weight Control
Conditions: Overweight;   Obese
Interventions: Other: Exercise Energy Expenditure 300 kcal/day;   Other: Exercise Energy Expenditure 600 kcal/day
6 Terminated Safety and Efficacy Study to Evaluate the Effect of SLV320 on Renal Function in Patients With Worsening Heart Failure
Condition: Acute Decompensated Heart Failure; Renal Dysfunction
Interventions: Drug: SLV320;   Drug: Placebo
7 Completed Metabolic Adaptation to Diabetes
Condition: Type 2 Diabetes
Intervention: Procedure: glucose clamp
8 Completed Hypoglycemia Associated Autonomic Failure in Type 1 DM, Q2
Condition: Type 1 Diabetes
Interventions: Drug: Alprazolam;   Other: control group
9 Active, not recruiting Mechanisms of Hypoglycemia Associated Autonomic Dysfunction, Q4-Atomoxetine
Condition: Type 1 Diabetes
Interventions: Drug: Atomoxetine;   Drug: Placebo
10 Active, not recruiting Mechanisms of Hypoglycemia Associated Autonomic Dysfunction Question 2
Condition: Type 1 Diabetes
Interventions: Drug: Alprazolam;   Drug: Placebo
11 Recruiting Investigation of Immune Disorders and Deficiencies
Conditions: Primary Immune Deficiencies;   Autoimmune Diseases;   Inflammatory Diseases;   Common Variable Immune Deficiencies;   Hypogammaglobulinemia
12 Completed Trial of Vascular Endothelial Growth Factor (VEGF), Bevacizumab, in Combination With Cytotoxic Chemotherapy for Endometrial Cancer
Condition: Endometrial Carcinoma
Intervention: Drug: carboplatin, paclitaxel, and bevacizumab
13 Recruiting Detection and Characterization of Infections and Infection Susceptibility
Conditions: Immune Disorders;   Chronic Granulomatous Disease;   Genetic Immunological Deficiencies;   Hyperimmunoglobulin-E Recurrent Infection Syndrome;   Recurrent Infections;   Unknown Immune Deficiency;   GATA2 Deficiency (MonoMAC),;   Nontuberculous Mycobacterial Infections;   Hyper IgE (Job s) Syndrome;   Leukocyte Adhesion Deficiency;   Susceptibility to Disseminated Infections;   Primary Immune Deficiency Disease (PIDD)
14 Completed Peer Interactions and Food Are Substitutable in Youth
Conditions: Activity Choices;   Caloric Intake;   Social Time
15 Unknown  Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Conditions: Scleroderma;   Interstitial Lung Disease
Interventions: Drug: Mycophenolate mofetil;   Drug: Cyclophosphamide;   Drug: Placebo
16 Completed Safety and Effectiveness of CD4-IgG2 in HIV-Positive Children
Condition: HIV Infections
Intervention: Drug: CD4-IgG2
17 Active, not recruiting The Natural History of Gene Expression in the Lung Cells of Non-Smokers, Smokers and Ex-Smokers in Health and Disease
Conditions: Chronic Obstructive Pulmonary Disease (COPD);   Smoking;   Smoking Cessation;   Chronic Bronchitis;   Emphysema
18 Completed Glutamine Supplementation in Cystic Fibrosis
Conditions: Cystic Fibrosis;   Immune Function
Interventions: Dietary Supplement: Glutamine;   Dietary Supplement: L-alanine
19 Unknown  Comparison Between Single and Triple Rubber Band Ligation for the Treatment of Hemorrhoids
Condition: Second-degree Hemorrhoids
Interventions: Procedure: Single hemorrhoidal ligation;   Procedure: Triple hemorrhoidal ligation
20 Completed Visilizumab for Treatment of Perianal Fistulas in Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: Visilizumab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years